Most cases of neuroleptic malignant syndrome develop between four to 14 days of the initiation of a new drug or an increase in dose.
The treatment team for neuroleptic malignant syndrome typically includes physicians, such as psychiatrists and intensivists, critical care nurses, pharmacists, and physical therapists. In some cases, consultants like neurologists and endocrinologists may also be involved in the care team. Close monitoring and communication among team members are essential for managing this serious condition effectively.
Neuroleptic malignant syndrome (NMS) is most commonly associated with antipsychotic medications, particularly typical or first-generation antipsychotics like haloperidol and fluphenazine. However, atypical or second-generation antipsychotics such as risperidone and olanzapine can also rarely cause NMS. Other medications like antiemetics and lithium have also been reported to induce NMS in some cases.
Severe cases of respiratory distress syndrome may develop into bronchopulmonary dysplasia with the development of scar tissue in the lungs.
Most cases of down syndrome are not inherited. Translocation Down syndrome can be inherited.
Malignant hypertension causes death in approximately 30% of cases
ICD-O-3
money
yes it is a very little chance you will get morquio syndrome in many cases
Syndrome evidence is the competence in theory of mind. Thsi is used in many court cases.
It is a rare syndrome (currently less than 100 confirmed cases worldwide).
A few cases of the disorder in girls have been reported. Women carriers usually do not have any symptoms. Women carriers can occasionally develop inflammation of the joints (gout ) as they get older.
A few cases of the disorder in girls have been reported. Women carriers usually do not have any symptoms. Women carriers can occasionally develop inflammation of the joints (gout ) as they get older.